U.S. FDA issued an EUA to Ortho-Clinical Diagnostics for VITROS Anti-SARS-CoV-2 IgG quantitative test
On Jul. 9, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to Ortho-Clinical Diagnostics, for the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Quantitative Test.
Quantitative serology tests that are traceable to a certified reference material were helpful for ongoing medical research to study the immune response to SARS-CoV-2.
Tags:
Source: U.S. Food and Drug Administration
Credit:
